Novartis India Profile
Key Indicators
- Authorised Capital ₹ 32.00 Cr
- Paid Up Capital ₹ 12.34 Cr
- Company Age 77 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 65.73 Cr
- Satisfied Charges ₹ 191.75 Cr
- Revenue Growth 0.88%
- Profit Growth 2878.49%
- Ebitda 140.06%
- Net Worth 12.14%
- Total Assets 2.65%
About Novartis India
Novartis India Limited (NIL) was founded in India on 13 December 1947 and has a glorious history of 77 years and one month. Its registered office is in Mumbai, Maharashtra, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 500672 and on the National Stock Exchange(NSE) under NOVARTIND.
The Corporate was formerly known as Ciba (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 32.00 Cr and a paid-up capital of Rs 12.34 Cr.
The company currently has active open charges totaling ₹65.73 Cr. The company has closed loans amounting to ₹191.75 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Novartis India Limited India are Shilpa Joshi as CFO and Nikhil Malpani as Company Secretary. Sanker Parameswaran, Jai Hiremath, Christopher Snook, and Three other members serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
Industry
What products or services does Novartis India Limited offer?
Novartis India Limited offers a wide range of products and services, including Immunity Boosters, Antioxidant Supplements, Vitamins & Supplements, Vitamins A-Z, Mineral Supplements, Nutritional Drinks, For Adults, Health Conditions, Pain Relief, Bone, Joint & Muscle Care.
Who are the key members and board of directors at Novartis India?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Murdeshwar  | Managing Director | 15-Jun-2019 | Current |
| Shilpa Joshi | CFO | 01-May-2022 | Current |
| Nikhil Malpani | Company Secretary | 27-Apr-2022 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanker Parameswaran | Director | 22-Jun-2020 | Current |
| Sandra Martyres | Director | 19-Apr-2016 | Current |
| Jai Hiremath | Director | 28-Jan-2006 | Current |
Christopher Snook  | Director Appointed In Casual Vacancy | 01-Aug-2008 | Current |
| Shilpa Joshi | Whole-Time Director and Cfo | 22-Nov-2022 | Current |
Financial Performance of Novartis India.
Novartis India Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 0.88% increase. The company also saw a substantial improvement in profitability, with a 2878.49% increase in profit. The company's net worth Soared by an impressive increase of 12.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Novartis India?
In 2023, Novartis India had a promoter holding of 70.68% and a public holding of 29.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shri Balaji Valve Components LimitedSanker Parameswaran is a mutual person
Acoris Research LimitedJai Hiremath is a mutual person
Novartis Comprehensive Leprosy Care AssociationShilpa Joshi is a mutual person
Hikal LimitedJai Hiremath is a mutual person
Franklin Templeton Trustee Services Private LimitedSandra Martyres is a mutual person
United Breweries LimitedNikhil Malpani is a mutual person
Charges (Loans)
₹65.73 Cr
₹191.75 Cr
Charges Breakdown by Lending Institutions
- Grindlays Bank : 45.20 Cr
- The Industrial Credit And Investment Corpn. Of India Ltd. : 20.00 Cr
- Citi Bank N. A. : 0.50 Cr
- The National Bank Of India Ltd. : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 1993 | Grindlays Bank | ₹45.00 Cr | Open |
| 13 Feb 1992 | The Industrial Credit And Investment Corpn. Of India Ltd. | ₹10.00 Cr | Open |
| 13 Feb 1992 | The Industrial Credit And Investment Corpn. Of India Ltd. | ₹10.00 Cr | Open |
| 17 Aug 1982 | Grindlays Bank | ₹2.00 M | Open |
| 25 Jun 1980 | Citi Bank N. A. | ₹5.00 M | Open |
How Many Employees Work at Novartis India?
Novartis India has a workforce of 59 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Novartis India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novartis India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
